Fyn inhibition rescues established memory and synapse loss in Alzheimer mice

Cited by (317)

Items 201–300 of 317

1. Critical role of mitosis in spontaneous late-onset Alzheimer’s disease; from a Shugoshin 1 cohesinopathy mouse model
   Chinthalapally V. Rao, Mudassir Farooqui, Adam Steven Asch, Hiroshi Y. Yamada · 2018 · Cell Cycle
2. Enhanced phagocytosis associated with multinucleated microglia via Pyk2 inhibition in an acute β-amyloid infusion model
   Ji‐Won Lee, Kaito Mizuno, Haruhisa Watanabe, In‐Hee Lee, Takuya Tsumita, Kyoko Hida, Yasutaka Yawaka, Yoshimasa Kitagawa, Akira Hasebe, Tadahiro Iimura et al. · 2024 · Journal of Neuroinflammation
3. Positron Emission Computed Tomography Imaging of Synaptic Vesicle Glycoprotein 2A in Alzheimer’s Disease
   Yanyan Kong, Shibo Zhang, Lin Huang, Chencheng Zhang, Fang Xie, Zhengwei Zhang, Qi Huang, Donglang Jiang, Junpeng Li, Weiyan Zhou et al. · 2021 · Frontiers in Aging Neuroscience
4. Advances in Recapitulating Alzheimer’s Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models
   Md Fayad Hasan, Eugenia V. Trushina · 2022 · Brain Sciences
5. Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis, and APP regulation
   Goce Taleski, Diana Schuhmacher, Henry K. Su, Jean‐Marie Sontag, Estelle Sontag · 2020 · Journal of Biological Chemistry
6. WS635 Attenuates the Anesthesia/Surgery-Induced Cognitive Impairment in Mice
   Jiefu Lin, Fuyi Shen, Jing Lü, Feng Liang, Yiying Zhang, Zhongcong Xie, Yuanlin Dong · 2021 · Frontiers in Aging Neuroscience
7. Alzheimer's disease: from molecular pathways to therapies
   Jing-Qiu Feng, Ling-Ling Yang, Luo Ya-xi, Xiu‐Qing Yao · 2026 · Molecular Biomedicine
8. New Metabolites from the Marine Sponge Scopalina hapalia Collected in Mayotte Lagoon
   Charifat Saïd Hassane, Gaëtan Herbette, Elnur Garayev, Fathi Mabrouki, Patricia Clerc, Nicole Joy de Voogd, Stéphane Greff, Ioannis P. Trougakos, Jamal Ouazzani, Mireille Fouillaud et al. · 2022 · Marine Drugs
9. Cancerome: A hidden informative subnetwork of the diseasome
   Mahdi Jalili, Ali Salehzadeh‐Yazdi, Marjan Yaghmaie, Ardeshir Ghavamzadeh, Kamran Alimoghaddam · 2016 · Computers in Biology and Medicine
10. Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease
    Jeffrey A. Zahratka, Yvonne Y. Shao, McKenzie L. Shaw, Kaitlin W. Todd, Shane V. Formica, Maria Khrestian, Thomas Jude Montine, James B. Leverenz, Lynn M. Bekris · 2016 · Neurobiology of Aging
11. Translational Scoring of Candidate Treatments for Alzheimer’s Disease: A Systematic Approach
    Jeffrey L. Cummings · 2020 · Dementia and Geriatric Cognitive Disorders
12. Protein kinase inhibitors as therapeutics in neurodegenerative and psychiatric disorders
    Tridente, Giuseppe, Jana, Ankit, Nath, Arnab, Ashraf, Ghulam Md · 2023 · Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
13. Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration
    Meghan Gage, Akhil A. Vinithakumari, Shankumar Mooyottu, Thimmasettappa Thippeswamy · 2022 · Frontiers in Microbiomes
14. EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma
    Mylan R Blomquist, Ryan Eghlimi, Angad Beniwal, Dustin Grief, David G. Nascari, Landon J. Inge, Chris Sereduk, Serdar Tuncali, Alison Roos, Hannah Inforzato et al. · 2024 · International Journal of Molecular Sciences
15. Tau-based therapies for Alzheimer’s disease: Promising novel neuroprotective approaches
    Carmen Laura Sayas · 2019 · Elsevier eBooks
16. Uncontrolled SFK-mediated protein trafficking in prion and Alzheimer's disease
    Edward Málaga Trillo, Katharina Ochs · 2016 · Prion
17. Commentary on Giralt et al.: PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease
    Baruh Polis, Hava Gil-Henn · 2018 · Experimental Neurology
18. Role of proline‐rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease
    Rahul Kewal Kumar, Vishvanath Tiwari, Sharmistha Dey · 2021 · European Journal of Neuroscience
19. Exploring the benefits of in-diet versus repeated oral dosing of saracatinib (AZD0530) in chronic studies: insights into pharmacokinetics and animal welfare
    Suraj Sundara Vasanthi, Nyzil Massey, Suresh Nair, Jonathan Paul Mochel, Lucas John Showman, Thimmasettappa Thippeswamy · 2023 · Frontiers in Veterinary Science
20. Repetitive Mild Closed-Head Injury Induced Synapse Loss and Increased Local BOLD-fMRI Signal Homogeneity
    Marija Markicevic, Francesca Mandino, Takuya Toyonaga, Zhengxin Cai, Arman Fesharaki‐Zadeh, Xilin Shen, Stephen M. Strittmatter, Evelyn M. R. Lake · 2024 · Journal of Neurotrauma
21. Activation of Phosphotyrosine-Mediated Signaling Pathways in the Cortex and Spinal Cord of SOD1G93A, a Mouse Model of Familial Amyotrophic Lateral Sclerosis
    Cinzia Mallozzi, Alida Spalloni, Patrizia Longone, Maria Rosaria Domenici · 2018 · Neural Plasticity
22. Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer’s Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling
    Sze Chung Yuen, Simon Ming‐Yuen Lee, Siu-wai Leung · 2021 · Journal of Alzheimer s Disease
23. Common therapeutic strategies for prion and Alzheimer’s diseases
    Saioa R. Elezgarai, Emiliano Biasini · 2016 · Biological Chemistry
24. Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors
    Giambattista Marotta, Francesca Massenzio, Jose Ortega, Debora Russo, Ilaria Penna, Federico Falchi, Giorgia Babini, Sabrina Petralla, Rita Scarpelli, Elena Roggiolani et al. · 2025 · Journal of Medicinal Chemistry
25. Cancer drugs with high repositioning potential for Alzheimer’s disease
    Jad Majeed, Marwan Noel Sabbagh, Min H. Kang, J. Josh Lawrence, Kevin Pruitt, Sarah S. Bacus, Ellie Reyna, Maddy Brown, Boris Decourt · 2023 · Expert Opinion on Emerging Drugs
26. Kinase inhibition in Alzheimer’s disease
    Soghra Bagheri, Ali Akbar Saboury · 2022 · Elsevier eBooks
27. Pyrimidines and Their Benzo Derivatives
    Tao Cao, Michael L. Martini, Kwang‐Su Park, H. Ümit Kanıskan, Jian Jun Jin · 2021 · Elsevier eBooks
28. Receptor protein tyrosine phosphatases control Purkinje neuron firing
    Alexander S. Brown, Pratap Meera, Gabe Quinones, Jessica Magri, Thomas S. Otis, Stefan M. Pulst, Anthony E. Oro · 2019 · Cell Cycle
29. Validation of a functional human AD model with four AD therapeutics utilizing patterned ipsc-derived cortical neurons integrated with microelectrode arrays
    Julbert Caneus, Kaveena Autar, Nesar Akanda, Marcella Grillo, Christopher J. Long, Max Jackson, Sarah Lindquist, Xiufang Guo, David Morgan, James J. Hickman · 2024 · Scientific Reports
30. A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning
    Maitray A. Patel, Mark J. Daley, L. Van Nynatten, M. Slessarev, G. Cepinskas, Douglas D. Fraser · 2024 · Clinical Proteomics
31. A public–private collaboration model for clinical innovation
    Craig D. Wegner, Bobbie Ann Mount, Christine M. Colvis · 2022 · Clinical and Translational Science
32. Prion Diseases
    Robert C.C. Mercer, Alex James McDonald, Erin Bove‐Fenderson, Cheng Fang, Bei Wu, David A. Harris · 2018 · Elsevier eBooks
33. Molecular imaging biomarkers in familial frontotemporal lobar degeneration: Progress and prospects
    Ruihan Wang, Hui Gao, Hongsheng Xie, Zhiyun Jia, Qin Chen · 2022 · Frontiers in Neurology
34. Novel therapeutic approaches for targeting Alzheimer’s disease
    Akruti Khodakiya, Sunita Chaudhary, Ankit Chaudhary, Bhupendra Gopalbhai Prajapati · 2024 · Elsevier eBooks
35. Inhibition of Src signaling induces autophagic killing of Toxoplasma gondii via PTEN-mediated deactivation of Akt
    Alyssa Hubal, Anusha Vendhoti, Charles N. Shaffer, Sarah Vos, Yalitza Lopez Corcino, Carlos S. Subauste · 2025 · PLoS Pathogens
36. Diet-incorporated saracatinib, a Src tyrosine kinase inhibitor, counteracts diisopropylfluorophosphate (DFP)-induced chronic neurotoxicity in the rat model
    Suraj S. Vasanthi, Nyzil Massey, Christina Meyer, Chong Wang, Thimmasettappa Thippeswamy · 2025 · Biomedicine & Pharmacotherapy
37. Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery
    Joël Mercier, Laurent Provins, Jonas O. Hannestad · 2017 · Elsevier eBooks
38. Neuroprotection in Alzheimer Disease
    Kewal K. Jain · 2019 · Springer protocols handbooks/Springer protocols
39. Uncovering the Early Events Associated with Oligomeric Aβ-Induced Src Activation
    Sandra Isabel Mota, Lígia Fão, Patrícia Coelho, Ana Cristina Rego · 2023 · Antioxidants
40. A Role for Cellular Prion Protein in Late-Onset Alzheimer's Disease: Evidence from Preclinical Studies
    Ricardo A. S. Lima‐Filho, Mauricio Martins Oliveira · 2018 · Journal of Neuroscience
41. Dose reduction in dynamic synaptic vesicle glycoprotein 2A PET imaging using artificial neural networks
    Andi Li, Bao Yang, Mika Naganawa, Kathryn M. Fontaine, Takuya Toyonaga, Richard E. Carson, Jing Tang · 2023 · Physics in Medicine and Biology
42. Palmitoyl-protein thioesterase-1 in health and disease
    Morgan M. Barnes, Renuka Raman, Sean Ekins · 2026 · Trends in Pharmacological Sciences
43. Identification of Two CDK5R1-Related Subtypes and Characterization of Immune Infiltrates in Alzheimer’s Disease Based on an Integrated Bioinformatics Analysis
    Xu Shao, Yanxian Yang, Jieyun Chen, Runping Zhao, Lei Xu, Xilong Guo, Yu Feng, Lina Qin · 2022 · Computational and Mathematical Methods in Medicine
44. Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours
    Chongxi Xu, Yi Ping Tang, Xing Lu, Ruiqi Chen · 2024 · Frontiers in Pharmacology
45. Emerging Mechanisms in Alzheimer’s Disease and Their Therapeutic Implications
    Stephen M. Strittmatter · 2018 · Biological Psychiatry
46. Seizures and Epilepsy in Dementia: Diagnosis and Management
    Laura Mantoan Ritter, Christer Nilsson · 2021 · Springer eBooks
47. Prospects and Challenges for Alzheimer Therapeutics
    Michael S. Wolfe · 2016 · Elsevier eBooks
48. SRC family kinase inhibition rescues molecular and behavioral phenotypes, but not protein interaction network dynamics, in a mouse model of Fragile X syndrome
    Vera Stamenković, Jonathan D. Lautz, Felicia M. Harsh, Stephen E.P. Smith · 2024 · Molecular Psychiatry
49. Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs—Protocols and Advice for the FDA to Meet the ALS Act Vision
    Sarfaraz K. Niazi · 2024 · International Journal of Molecular Sciences
50. Recent Updates on Alzheimer’s Disease: Pathogenesis, Pathophysiology, Molecular Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate Disease
    Arun Kumar Mishra, Alankar Srivastava, Varsha Raj, Vipin Saini, Gyas Khan, Harpreet Singh, Amrita Mishra, Sarvesh Paliwal · 2024 · Current Alzheimer Research
51. Fyn-dependent Tau microcluster formation seeds and boosts extensive Tau pathology
    Yingjie Li, Wending Qi, Le Chen, Fan Chu, Wenfeng Jiang, Zifeng Xu, Yuexin Luo, Xudong Hu, Jürgen Götz, Chuanzhou Li · 2025 · Acta Neuropathologica
52. Research in Rare Disease: From Genomics to Proteomics
    Jessica Lacoste · 2018 · Assay and Drug Development Technologies
53. Postoperative cognitive dysfunction: advances based on pre-clinical studies
    So Yeong Cheon, Bon‐Nyeo Koo · 2018 · Anesthesia and Pain Medicine
54. Chromatin accessibility in neuropsychiatric disorders
    Gabor Egervári · 2021 · Neurobiology of Learning and Memory
55. Insights to develop tau‐directed therapeutics to protect the synaptic integrity for tauopathies
    Eunji Cha, Hak Joong Kim, Sang Min Lim · 2023 · Bulletin of the Korean Chemical Society
56. Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer’s disease
    Himanshu Layal, Jitumani Rajbongshi, Rohit Kumar, Shambhavi Pandey, Rajeev Mishra, Pramod Kumar Yadav · 2025 · Neuroscience
57. Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants
    Summer L. Thompson, Carol A. Gianessi, Stephanie S. O’Malley, Dana Anne Cavallo, Julia M. Shi, Jeanette M. Tetrault, Kelly S. DeMartini, Ralitza V. Gueorguieva, Brian P. Pittman, John Harrison Krystal et al. · 2021 · Frontiers in Psychiatry
58. Frontotemporal dementia mutant tau (P301L) locks Fyn in an open, active conformation conducive to nanoclustering
    Christopher Small, Ramón Martínez‐Mármol, Tristan P. Wallis, Rachel S. Gormal, Jürgen Götz, Frédéric A. Meunier · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
59. Src and Abl as Therapeutic Targets in Lung Cancer: Opportunities for Drug Repurposing
    Raquel Ramos, Carlos Sousa, Nuno Vale · 2025 · Pharmaceuticals
60. Astrocytic Igfbp2 Promotes Spontaneous Seizures in a Mouse Model of Mesial Temporal Lobe Epilepsy
    Shinichi Kinoshita, Nobuyoshi Matsumoto, Shota Morikawa, Yuji Ikegaya, Ryuta Koyama · 2025 · Glia
61. Receptor tyrosine kinases in Alzheimer's disease: Mechanistic insights and therapeutic implications
    Pengyu Zhao, Zelin Cao, Wioletta Rozpędek‐Kamińska · 2026 · Neurochemistry International
62. Polydopamine Modified with Brain Targeting Peptide Rabies Virus Glycoprotein for Treatment of Alzheimer’s Disease by Inhibiting Oxidative Stress and Inflammatory Response
    Heling Chu, Yihao Sun, Chuyi Huang, Lei Wang, Qihao Guo, Lixian Jiang · 2026 · International Journal of Nanomedicine
63. Functional sQTLs regulating PTK2B exon 31 splicing uncover an RNA-dependent modulation of its kinase activity and cellular phenotype
    Masahide Kato, Ayaka Isazawa, Ai Ohki, Akari Fujita, Makoto Araki, Motoaki Yanaizu, Yoshihiro Kino · 2026 · Cell Communication and Signaling
64. Protein kinases as therapeutic targets in Alzheimer’s disease: challenges, insights, and new frontiers
    Chanwool Tak, Swapnil Pandurang Bhujbal, Jung‐Mi Hah · 2026 · Medicinal Chemistry Research
65. Native PLGA nanoparticles attenuate disease pathology via multiple pathways in 5xFAD Alzheimer's model
    Govindarajan Karthivashan, Shuai Wang, Qi Wu, Abhishek Dahal, Xiuju Li, Danny Galleguillos, Simonetta Sipione, Gopal Thinakaran, Satyabrata Kar · 2026 · Alzheimer s & Dementia
66. Tandem Mass Spectrometry as Strategy for the Selective Identification and Quantification of the Amyloid Precursor Protein Tyr682 Residue Phosphorylation Status in Human Blood Mononuclear Cells
    Pierluigi Reveglia, Rosarita Nasso, Antonella Angiolillo, Lucia Lecce, Carmela Paolillo, Samantha De Tullio, Monica Gelzo, Alfonso Di Costanzo, Carmela Matrone, Gaetano Corso · 2021 · Biomolecules
67. Polybrominated diphenyl ethers isolated from the marine sponge Lendenfeldia chondrodes collected in Mayotte
    Charifat Saïd Hassane, Florent Tintillier, Pierre-Éric Campos, Gaëtan Herbette, Nicole Joy de Voogd, Jamal Ouazzani, Mireille Fouillaud, Laurent Dufossé, Anne Gauvin‐Bialecki · 2023 · Natural Product Research
68. Genetic Causes of Alzheimer’s Disease and the Neuroprotective Role of Melatonin in its Management
    Sonali Sundram, Rishabha Malviya, Rajendra Awasthi · 2022 · CNS & Neurological Disorders - Drug Targets
69. Therapeutic Targeting of Antineoplastic Drugs in Alzheimer’s Disease: Discovered in Repurposed Agents
    Mini Dahiya, Anil Kumar, Monu Yadav, Pratibha Dhakla, Shiva Tushir · 2023 · Springer eBooks
70. CD11c is not required by microglia to convey neuroprotection after prion infection
    James A. Carroll, James F. Striebel, Chase Baune, Bruce W. Chesebro, Brent Race · 2023 · PLoS ONE
71. Pyk2 Overexpression in Postsynaptic Neurons Blocks Aβ 1-42 -induced Synaptotoxicity in a Microfluidic Co-Culture Model
    Devrim Kilinc, Anaïs-Camille Vreulx, Tiago Mendes, Amandine Flaig, Diego Marques Coelho, Maxime Verschoore, Florie Demiautte, Philippe Amouyel, Neuro-CEB Brain Bank, Fanny Eysert et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
72. Drug Discovery from Medicinal Plants against Alzheimer's Disease
    Mona M. Marzouk, Mai Mohammed Farid, Nesrine Mahmoud Hegazi, Shahira M. Ezzat · 2023 · Wiley eBooks
73. Aging-Dependent Loss of Connectivity in Alzheimer’s Model Mice with Rescue by mGluR5 Modulator
    Francesca Mandino, Xilin Shen, Gabriel Desrosiers-Grégoire, David A. O’Connor, Bandhan Mukherjee, Ashley Owens, An Qu, John A. Onofrey, Xenophon Papademetris, M. Mallar Chakravarty et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
74. Targeting Fyn Kinase for Alleviation of Cognitive Impairment in Streptozocin-Induced Alzheimer’s Disease in Mice by Loperamide; An Experimental and in Silico Analysis
    Halima Qadir, Syed Haroon Hussain, Amama Ghaffar, Fawad Ali Shah, Sagheer Ahmed · 2025 · Neurochemical Research
75. A hydrophilic interaction UPLC-MS/MS quantitative method for the quantification of saracatinib in the human liver microsome matrix and its application in in vitro metabolic stability assessment
    Mohamed W. Attwa, Adnan A. Kadi · 2026 · Analytical Methods
76. Pyk2-PSD95 activation alleviates cognitive dysfunction by modulation of hippocampal synaptic structural plasticity via NMDAR2A in mice with neuropathic pain
    Qingbiao Song, Yijia Zhang, Zhiyu Zhang, Xia Liu, Renmao Hou, Hongjing Jia, Shishan Wang, Lina Sun, Yongxin Liu, Rui Zhang et al. · 2026 · Neuropharmacology
77. Pyk2 plays a critical role in synaptic dysfunction during the early stages of Alzheimer’s disease
    Quentin Rodriguez, Floriane Payet, Karina Vargas-Baron, Eve Borel, Fabien Lanté, Sylvie Boisseau, Béatrice Blot, Jean‐Antoine Girault, Alain Buisson · 2026 · Molecular Neurodegeneration Advances
78. Targeting Intraplatelet Signaling Pathways as Potential Antithrombotic Strategy
    Patrick André · 2017 · Springer eBooks
79. Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease ☆
    Gabriel S. Stephens, Jason C. You, Chia-Hsuan Fu, Jeannie Chin · 2017 · Elsevier eBooks
80. New targets for old drugs
    Navanath Kumbhar, M.A. Aparna, Snehal K. Nimal, Pallavi Shewale, Sagar S. Barale, Rajesh Nivarti Gacche · 2023 · Elsevier eBooks
81. NMDA Receptors in Health and Disease
    Yue‐Qiao Huang · 2024 · Physiology
82. ATRI and ACTC: Academic Programs to Accelerate Alzheimer’s Disease Drug Development
    Paul S. S Aisen, Rema Raman, Michael S. Rafii, Reisa Anne Sperling, Ronald Carl Petersen · 2022 · Cambridge University Press eBooks
83. cAMP-Fyn signaling in the dorsomedial striatum direct pathway drives excessive alcohol use
    Yann Ehinger, Nadège Morisot, Khanhky Phamluong, Samuel A. Sakhai, Drishti Soneja, Martín F. Adrover, Veronica A. Alvarez, Dorit Ron A · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
84. Fyn kinase inhibition using AZD0530 improves recognition memory and reduces depressive-like behaviour in an experimental model of Parkinson’s disease
    Bianca Guglietti, Laura M. Carr, Benjamin Ellul, Sanam Mustafa, Frances Corrigan, Lyndsey E. Collins‐Praino · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
85. Neuronal Transcriptome Disruption, Tau Accumulation and Synapse Loss in Alzheimer’s Knock-in Mice Require Cellular Prion Protein
    Austin J. Stoner, Li Fu, LaShae Nicholson, Chao Zheng, Takuya Toyonaga, Joshua M. Spurrier, Will Laird, Zhengxin Cai, Stephen M. Strittmatter · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
86. Ultrasound Induced Blood-brain Barrier Opening on Rodents : from Nanoparticles Delivery to a Therapy for Alzheimer’s Disease
    Matthieu Gerstenmayer · 2018 · theses.fr (ABES)
87. Alzheimer?s disease: A Common Form of Neurodegeneration
    Prabhat Shukla, Neeru Tyagi · 2015 · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences
88. BIOLOGICAL SCIENCES: Neuroscience, cell biology MTSS1/Src family kinase Dysregulation Underlies Multiple Inherited Ataxias
    Alexander S. Brown, Pratap Meera, Banu Altindag, Ravi Chopra, Emma Perkins, Sharan Paul, Daniel R. Scoles, Eric Tarapore, Mandy Jackson, Vikram G. Shakkottai et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
89. Alzheimer’s Disease - Clinical Trials
    Gaetano Romano · 2018 · Materials and Methods
90. Role of Industry
    D. J. Hayes, Katherine J. Escott · 2022 · Royal Society of Chemistry eBooks
91. Saracatinib, em Busca da Cura Definitiva da Doença de Alzheimer
    Ana Rita Reis, Catarina Maria · 2022 · Boletim da Sociedade Portuguesa de Química
92. Faculty Opinions recommendation of Prions activate a p38 MAPK synaptotoxic signaling pathway.
    John Silke · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
93. Faculty Opinions recommendation of Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease.
    Bernadette Allinquant · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
94. Lysosomal Dysfunction in Down Syndrome and Alzheimer Mouse Models is Caused by Selective V-Atpase Inhibition by Tyr 682 Phosphorylated APP βCTF
    Eunju Im, Ying Jiang, Philip H. Stavrides, Sandipkumar Darji, Hediye Erdjument‐Bromage, Neubert A. Thomas, Matteo Bordi, Jun Yong Choi, Ju‐Hyun Lee, Ralph A. Nixon · 2022 · SSRN Electronic Journal
95. Prion Protein Complex with mGluR5 Mediates Amyloid-ß Synaptic Loss in Alzheimer’s Disease
    Graham P. Roseman, Li Fu, Stephen M. Strittmatter · 2023 · Springer eBooks
96. Carbohydrates and Carbohydrate‐Based Therapeutics in Alzheimer's Disease
    Ana Marta de Matos, João de Barros, Amélia P. Rauter · 2023
97. Mechanisms of epileptogenesis and disease-modification in experimental models of epilepsy
    Marson Rubianto Eka Putra · 2021
98. The organophosphate nerve agent model of epilepsy and disease mitigation by saracatinib
    Meghan Gage · 2022
99. Additional file 1 of Neuronal transcriptome, tau and synapse loss in Alzheimer’s knock-in mice require prion protein
    Austin J. Stoner, Li Fu, LaShae Nicholson, Chao Zheng, Takuya Toyonaga, Joshua M. Spurrier, Will Laird, Zhengxin Cai, Stephen M. Strittmatter · 2023 · Figshare
100. Diet-Incorporated Saracatinib, a Src Tyrosine Kinase Inhibitor, Counteracts Diisopropylfluorophosphate (Dfp)-Induced Chronic Neurotoxicity in the Rat Model
     Thimmasettappa Thippeswamy, Suraj Sundara Vasanthi, Nyzil Massey, Christina Meyer · 2025 · SSRN Electronic Journal